ACTR-43. GENOMIC ANALYSIS OF RESPONDERS OF PHASE II TRIAL OF TEMOZOLOMIDE AND TRC-102 (BASE EXCISION REPAIR INHIBITOR) IN BEVACIZUMAB-NAÏVE GLIOBLASTOMA AT FIRST RECURRENCE

Manmeet Ahluwalia, Harshil Dhruv, Jaleh Fallah, Michael Berens, Jan Drappatz, Xiaobu Ye, Glenn Lesser, Timothy Cloughesy, Tobias Walbert, Matthias Holdhoff, David Peereboom, Louis Nabors, Patrick Wen, Stuart Grossman, Lisa Rogers

Research output: Contribution to conferencePresentation

Original languageAmerican English
DOIs
StatePublished - Nov 11 2019
EventNeuro-oncology -
Duration: Nov 11 2019 → …

Conference

ConferenceNeuro-oncology
Period11/11/19 → …

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this